Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Share-based Compensation (2019 - 2026)

Alx Oncology Holdings' Share-based Compensation history spans 5 years, with the latest figure at $6.7 million for Q4 2023.

  • On a quarterly basis, Share-based Compensation rose 6.77% to $6.7 million in Q4 2023 year-over-year; TTM through Dec 2023 was $26.3 million, a 10.21% increase, with the full-year FY2025 number at $12.6 million, down 53.57% from a year prior.
  • Share-based Compensation hit $6.7 million in Q4 2023 for Alx Oncology Holdings, down from $7.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ALXO hit a ceiling of $7.0 million in Q3 2023 and a floor of $60000.0 in Q2 2019.
  • Historically, Share-based Compensation has averaged $3.7 million across 5 years, with a median of $4.2 million in 2021.
  • Biggest five-year swings in Share-based Compensation: soared 4655.0% in 2020 and later dropped 21.59% in 2021.
  • Tracing ALXO's Share-based Compensation over 5 years: stood at $75000.0 in 2019, then soared by 2224.0% to $1.7 million in 2020, then skyrocketed by 226.22% to $5.7 million in 2021, then grew by 10.71% to $6.3 million in 2022, then grew by 6.77% to $6.7 million in 2023.
  • Business Quant data shows Share-based Compensation for ALXO at $6.7 million in Q4 2023, $7.0 million in Q3 2023, and $6.2 million in Q2 2023.